Although the clinical implications of BRAWNIN remain unexplored to date, the fact that BRAWNIN expression positively regulates cortical connectivity in a mouse model of altered axonal development [77] suggest it could have a therapeutic potential in neurodevelopmental and neuromuscular diseases. This evidence concerns the gene UQCC6 and neuromuscular disease.